claimgotdeniedAnalyze

Austedo (deutetrabenazine) prior authorization denied appeal

VMAT2 inhibitor for tardive dyskinesia and Huntington's chorea

To appeal a denied prior authorization for Austedo (deutetrabenazine), file a written appeal within 180 days. The appeal must cite the insurer's clinical policy, include a letter of medical necessity from the prescriber, and document each criterion the policy requires. The most common winning evidence is documented prior therapy history and a specialist letter.

Typical PA criteria

  • Tardive dyskinesia or Huntington's chorea diagnosis
  • Documented AIMS score or severity assessment
  • Neurology or psychiatry prescriber
  • Contraindications ruled out (untreated depression, suicidality for HD)

Why your PA was denied

  • AIMS or severity documentation missing
  • Non-specialist prescriber
  • Preferred VMAT2 (Ingrezza) not tried
  • Contraindication not addressed

Evidence that overturns the denial

  • ✓AIMS score at baseline
  • ✓Diagnosis and etiology documented (offending antipsychotic if TD)
  • ✓Neurology/psychiatry letter
  • ✓Suicide-risk assessment for HD

Austedo XR (once-daily) simplifies dosing vs. twice-daily. Ingrezza is a competing VMAT2 inhibitor with different formulary preference by plan.

Draft a Austedo (deutetrabenazine) appeal letter

Free analysis identifies the cited policy and missing evidence. Then a finished letter that maps your chart to the criteria.

Draft my appeal letter

FAQ

Why was my Austedo (deutetrabenazine) prior authorization denied?+

The most common reasons are: AIMS or severity documentation missing; Non-specialist prescriber; Preferred VMAT2 (Ingrezza) not tried. Your denial letter names the specific criteria you did not meet.

How do I appeal a Austedo (deutetrabenazine) denial?+

File a written appeal within 180 days that cites the insurer's clinical policy, includes a letter of medical necessity from the prescriber, and documents the criteria the insurer requires.

What evidence overturns a Austedo (deutetrabenazine) denial?+

AIMS score at baseline; Diagnosis and etiology documented (offending antipsychotic if TD); Neurology/psychiatry letter.

What if the plan excludes Austedo (deutetrabenazine) entirely?+

Plan exclusions are different from medical-necessity denials. Check the Summary Plan Description. If the drug is fully excluded, an appeal will not overturn it; you may need a formulary exception or manufacturer assistance program.

Other drugs

Keep reading

Not legal or medical advice. This page is a self-help resource. You make your own decisions. Strip personal identifiers (name, date of birth, address, member ID) from any document before uploading or sharing. The information here summarizes commonly-published payer policies and federal rules; confirm against your specific plan document and the current denial letter before acting.